SEARCH RESULT

Total Matching Records found : 184

Anatomy of Indian capitalism by Himanshu

Ratan Tata has initiated an interesting debate on the nature of India’s capitalist class. His characterization of this class as crony capitalists may not be out of place given recent evidence on a politics, media, judiciary and corporate nexus.Crony capitalism is a system in which businesses multiply their wealth not by fair rules of the market, but through their nexus with governments. Classic examples are the distribution of legal permits,...

More »

The Real Concern by Ashok V Desai

A patent is an artificial property right; it is created by the government, and would not exist if there were no government or if it did not grant patents. It is then for the government to decide whether to grant a patent or not. But a government would not normally make the decision arbitrarily; it would follow some rules. The rules universally followed are novelty, non-obviousness and commercial value. A...

More »

Foreign bias finger at PMO on cheap drugs

Multinational drug companies appear to have used the Prime Minister’s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said. In a joint letter to Prime Minister Manmohan Singh, 50 NGOs said the PMO had asked the ministry of health and the departments of legal affairs and industrial policy to examine intellectual property rights issues raised by foreign pharmaceutical...

More »

Patent concerns by CP Chandrasekhar

The discussion paper on compulsory licensing of patents will have achieved its purpose if it can lead to a proactive policy in the area of drugs and health. IN a proactive move to ensure a fair balance between protection of intellectual property rights and protection of the public interest, the Department of Industrial Policy and Promotion (DIPP) of the Ministry of Commerce and Industry has chosen to put out a discussion...

More »

From approval to appraisal

The government’s subtle, but significant, move to divest the Genetic Engineering Approval Committee (GEAC) of its job of approving the genetically modified (GM) products and convert it into merely a GM appraisal body has taken the biotechnology sector by surprise. The Gazette notification to this effect replaces the word “approval” in the committee’s nomenclature with “appraisal”, thus making it the “Genetic Engineering Appraisal Committee”. One obvious reason for doing so...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close